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Abstract  
We systematically reviewed the randomised controlled trial (RCT) evidence for long-term (>12 
months) weight management interventions for obese men in contrast to women to help understand 
whether programmes should be designed differently for men.  
 
We searched 11 databases up to October 2014. Twenty-two RCTs reported data separately for men 
and women in weight loss or weight maintenance interventions.   
 
We found men were under-represented in RCTs of weight loss interventions open to both sexes.  Men 
comprised 36% of participants (4771 from 13,305 participants).  Despite this, men were 11% (95% CI 
8% to 14%, p<0.001) more likely to be trial completers compared to women. The trials did not report 
service user consultation and none were designed to investigate whether men and women responded 
differently to given interventions.  Our meta-analysis of 13 trials showed no significant difference in 
weight loss between men and women, either for weight loss in kg ( p=0.90) or percentage weight loss 
(p=0.78), although men tended to lose more weight with intensive low fat reducing diets, with or 
without meal replacements, and structured physical activity/exercise programmes than women. 
Orlistat was less beneficial for men for weight maintenance. Individual support and tailoring appeared 
more helpful for men than women. 
 
We found evidence that men and women respond differently to, and have different preferences for, 
varying types of weight management programme.  We suggest that it is important to understand men’s 
views on weight loss, as this is likely to also improve the uptake and effectiveness of programmes for 
men. 
 
Key words: Weight loss, weight maintenance, men and women, systematic review 
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Introduction 
US data from 2007 to 2010 show that 35.1% of men and 36.4% of women were obese [1].   In 
England in 2013, 26% of men and 24% of women were obese [2], with the UK Foresight Report [3] 
predicting that more men (47%) will be obese than women (36%) by 2025.  Yet men are under-
represented in randomised trials of weight loss interventions, and in both health care based and 
commercial weight management programmes.   
 
In a systematic review, Pagoto and colleagues [4] found that only 27% of participants in randomised 
trials were men, although the percentage was higher in interventions for obesity with related co-
morbidities (36% men).  There was also a trend towards lower participation by men in group-based 
interventions (24%), compared with individual counselling (29%) or mail/e-mail/internet (34%); 
however, the male/female mix of the group-based interventions was not specified.  In another 
systematic review [5], sex was not a predictor of dropout in weight loss interventions, suggesting that 
where men are included in intervention studies, they are no more or less likely than women to 
withdraw. 
 
In the weight loss Counterweight programme in 65 general practices in seven UK regions, only 23% 
of participants were men [6].  When services were not sex-specific, men comprised only 10.7% of 
34,271 adults referred from primary health care to one UK commercial weight loss programme 
(Slimming World) [7], and 10.5% of 29,326 adults referred to a different commercial programme 
(Weight Watchers) [8].  Thus UK figures suggest men may be even less likely than women to attend 
commercial weight loss programmes than programmes provided by the National Health Service 
(NHS).  Similarly, in the US National Weight Control Registry [9] only 20% of participants are men. 
Thus perceptions about the content of weight loss interventions may influence attendance, as has been 
demonstrated by the success of the Football Fans In Training (FFIT) weight loss trial [10], where the 
content of the trial was designed to attract men. 
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Other reasons for the under-representation of men may include a greater reluctance to change their 
current lifestyle than women [11] or sociocultural influences encouraging men to maintain a larger, 
more muscular, masculine body size [12].  Furthermore, masculinity, as a culturally normative ideal of 
male behaviour, is  constructed as the opposite of femininity [13] and weight loss programmes and 
facilities, could be seen as feminised spaces [14,15]. Similarly, men could distance themselves from 
the feminised realm of dieting, where women are  the ‘experts’ and dieting is viewed as a feminine 
activity that is about looking slim and pretty, which is linked to vanity [13,16]. 
 
A recent systematic review [17] of the effectiveness of men-only weight loss and weight maintenance 
interventions concluded that men-only programmes may effectively engage and assist men with 
weight loss but the evidence base for men-only interventions was lacking.   
 
As part of a series of quantitative and qualitative systematic reviews on the evidence for weight 
management for men funded by the National Institute for Health Research Health Technology 
Assessment programme (http://www.nets.nihr.ac.uk/projects/hta/0912701), we systematically 
reviewed the randomised trial evidence for weight management interventions for men in contrast to 
women to help better understand whether programmes should be designed differently for men and 
women.   
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Methods 
This was one of six systematic reviews undertaken for the ROMEO (Review Of MEn and Obesity) 
project, a mixed-methods synthesis of evidence for weight loss management for men.  All of the 
reviews were undertaken according to a pre-specified protocol (PROSPERO number CRD 
42011001479). 
 
Search strategy 
Searches were run in CINAHL, PsycINFO, the Cochrane Library, the Database of Abstracts of 
Reviews of Effects, as well as hand searching the reference lists of included studies (latest search 
October 2014).  No language restrictions were imposed on the searches. Publications prior to 2001 
were excluded from this database search, as we hand-searched the continuously updated database of 
long-term randomised controlled trials (RCTs) initiated for our previous health technology assessment 
[18], for publications prior to 2001.  This incorporates results from highly sensitive searches of 
MEDLINE, MEDLINE-in-Process, and Embase. We contacted the UK Association for the Study of 
Obesity, Dieticians in Obesity Management (DOM UK), commercial organisations and the Men’s 
Health Forum project advisory group from the UK and Republic of Ireland for studies. An example of 
the literature search strategy is provided in supplementary information, Table S1. The full search 
strategies are available from the first author. 
 
Study inclusion criteria 
We included RCTs of men and women with BMI of ≥30kg/m2 (or BMI ≥28 kg/m2 and cardiac risk 
factors) where outcome data were presented separately by sex in each trial, to allow direct, and 
therefore more scientifically reliable, comparison between men and women.  Trials had to have a 
duration and/or follow-up of at least one year.  We considered diet, physical activity, behaviour 
change and orlistat interventions or combinations of any of these, compared with control treatment, 
alternative interventions or placebo comparators.  We did not consider bariatric surgery, 
complementary therapy, non-diet products for weight loss available solely over the counter, or 
smoking cessation and weight loss interventions given together.  Studies with participants selected 
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because they all had psychotropic medication, learning disability or diagnosed eating disorders were 
excluded. 
 
Types of outcomes 
Studies had to explicitly mention weight loss or weight loss maintenance as a main aim to be eligible 
for inclusion.  We considered the following types of outcome: 
Primary outcome: weight change 
Secondary outcomes: waist circumference; cardiovascular risk factors (total cholesterol, high-density 
lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, fasting 
glucose, glycosylated haemoglobin  (HbA1c), systolic and diastolic blood pressure); disease specific 
outcomes (e.g. diabetes); adverse events; quality of life outcomes; process outcomes. 
 
Data extraction and quality assessment 
One reviewer (CR) independently screened titles and abstracts of all identified items.  Full text copies 
of all potentially relevant reports were obtained and independently assessed for eligibility (AA, CR).  
One reviewer extracted details of study design, methods, participants, interventions and outcomes 
(CR).  The data extraction was then checked by a second reviewer (AA) and any errors were 
corrected.  Two reviewers (CR, AA) independently assessed the quality of studies with the Cochrane 
Collaboration’s tool for assessing risk of bias [19].  We used the Cochrane-Campbell Methods Group 
Equity Checklist [20] to assess the effect of interventions reported upon disadvantaged groups and/or 
considerations of impact on reducing socioeconomic inequalities, which we modified for use with 
primary studies, in keeping with guidance from the Cochrane Public Health Group [21].  Any 
disagreements or uncertainty were resolved by discussion between the two reviewers.  A third 
reviewer was not required to act as an arbitrator.  
 
Data analysis 
Where possible, we imported data into Review Manager Software (version 5.1) for data synthesis.  For 
continuous outcomes we report mean difference (MD) and risk ratio (RR) for dichotomous data, with 
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95% confidence intervals (CIs).  Due to the inherent heterogeneity in studies of obesity interventions, 
where study results could be quantitatively pooled we used random effects meta-analysis throughout.  
For meta-analysis plots of only one study we used fixed effects.  We used visual inspection and the I2 
statistic to assess heterogeneity in forest plots [22].  Planned funnel plot analysis to investigate 
reporting biases for forest plots was not possible owing to the limited number of studies.  We used the 
methods reported in our previous technology assessment [18] to derive weight changes and standard 
deviations, where missing. 
 
We analysed the proportion of participants completing the study including studies that reported the 
rate of drop-out.  The risk difference and its confidence interval between men and women were 
calculated. 
 
For the analysis of differences in weight change between men and women, MD was calculated for 
both men and women where more than one group was reported. Studies with no baseline weight 
values were excluded from the analysis of weight difference; in the analysis of percent weight loss the 
MD was divided by the baseline weight.  For each study, the number of participants, N, MD of weight 
or percent weight loss from baseline and its standard deviation were entered into Review Manager in a 
random effects model. 
 
Planned subgroup analyses 
Subgroup analyses were planned to explore whether the effectiveness of interventions differed 
according to whether all participants were selected on the basis of newly diagnosed or pre-existing 
obesity related co-morbidities (e.g. diabetes, hypertension) or not.  This was not possible owing to the 
limited quantity of data and heterogeneity of the studies.  Sufficient data were also not available to 
explore the effect of deprivation, age, and ethnicity on effectiveness, or to explore the effect of 
assumed values for weight on meta-analyses.  
 
Results 
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Description of the trials 
Details of the flow chart for the result of the literature search are provided in supplementary 
information, Figure S1.  A detailed description of all the characteristics of the included trials is 
provided in supplementary information Table S2.   
 
Twenty-two RCTs were included.  Men comprised 36% of participants in 18 of the trials (4771 from a 
total of 13,305 participants); in four trials numbers of men recruited were unclear [23-26]. Eleven 
trials [23,26-35] were conducted in the USA; six [24,25,36-39] in Finland and one trial from each of 
the following locations: Canada [40], Israel [41], Scandinavia [42], Sweden [43,43]and the UK [44].  
 
The majority of trials considered interventions for weight loss, rather than weight loss maintenance. 
No trials were designed to directly address our research question: do men and women respond 
differently to weight loss interventions? Seven trials [24,25,31-34,39] considered low fat reducing 
diets (LFRDs) either alone or in conjunction with physical activity and/or behavioural therapy.  Ross 
and colleagues [40] examined physical activity and healthy eating advice with behavioural therapy.  
Three trials [27,35,41] considered different types of reducing diet.  Heitzmann [23] considered 
different types of behaviour change techniques. Two trials compared intensive inpatient rehabilitation 
programmes with community programmes [36,37].  Two trials [38,44] considered different types of 
weight loss service provider.  The remaining trials considered spouse involvement [26], modification 
of the home environment [28], telephone or mail contact [30], and varying monetary contracts [29].   
 
Three trials considered weight loss maintenance: lifestyle counselling including a 600kcal/day deficit 
low fat diet and orlistat or placebo [42], intermittent versus on demand very low calorie diets [43], and 
monetary contracts [29].  
 
Of the seven linked reports, five were identified as relevant ancillary studies for this review. These 
included two trials examining spousal effects [45,46]; one investigating differences in body image 
between men and women [47] and one investigating the effects of weight loss interventions on bone 
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mineral density [48].  One report provided additional data for risk factors not included in the main trial 
report [49] and one provided extended follow-up data [50].  One linked report only provided data for 
men [51], and is not discussed here.   
 
Nine trials recruited participants with concomitant medical conditions: six [23,25,26,33,35,38] 
recruited participants with type 2 diabetes, two [34,39] recruited participants with impaired glucose 
tolerance, one recruited participants who were either diagnosed with pre-diabetes mellitus or 
metabolic syndrome [27] and one [42] recruited participants with hyperlipidaemia.  In total, 13,305 
men and women were enrolled in the trials.  Where age was reported by sex [25,29,36-38,40,47,48], 
mean ages ranged from 39 to 62 years for men and 37 to 59 years for women (median 53 years for 
men and 51 years for women).  The highest reported mean BMI for men was 42.7 [36] and 43.6 for 
women [36], while the lowest was 29.7 [39] and 30.53 [29] respectively.  The period of follow up 
ranged from one to eight years (median two years). 
 
Quality of the trials  
Trials were of moderate quality with poor reporting of sequence generation and allocation 
concealment.  Most trials failed to use full intention to treat analysis or blinded outcome assessment.  
Equity and sustainability items, such as sociodemographic differences between withdrawals and 
exclusions, process measures or fidelity checks were mostly not considered or reported. A detailed 
summary of the quality assessment for the individual trials is provided in supplementary information 
Tables S3 and S4. 
 
Engagement of men and women 
Recruitment and attrition of men and women 
Nine trials [27,29,34,36-38,40,43,44] provided data that could be included in the analysis comparing 
the number of men and women who completed the trials.  The total analysis included 3943 
participants, with 1255 men (31.8%) and 2688 women (68.2%) (Tables 1 and 2).  The results show 
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that men were 11% (95% CI 8% to 14%, p<0.001) more likely to be trial completers compared to 
women.  
Table 1 Studies included in the analysis of attrition by sex 
 % men 
randomised 
Number 
randomised 
Number 
completed 
% completed of 
number 
randomised by sex 
  Men Women Men Women Men Women 
Evans 2012 [27] 44.6 58 72 31 40 53 56 
Hakala 1993 [36] 33.3 20 40 18 35 90 88 
Hakala 1994 [37] 30.0 18 42 13 30 72 71 
Jeffery 1984 [29] 48.7 55 58 53 55 96 95 
Jolly 2011 [44] 30.7 227 513 162 182 71 36 
Korhonen 1987 [38] 50.0 40 40 38 33 95 83 
Lantz 2003 [43] 25.8 86 248 35 82 41 33 
Ross 2012 [40] 29.8 146 344 121 275 83 80 
West 2008 [34] 31.3 605 1331 416 889 69 67 
Total 31.8 1255 2688 887 1621 71 60 
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Table 2 Contingency table and analysis results for studies included in the analysis of 
attrition for men and women 
 
 
 
 
 
 
 
 
 
  
   
 
Completed 
study 
Did not complete study Total Proportion 
completing 
Male 887 368 1255 0.71 
Female 1621 1067 2688 0.60 
Total 2508 1435 3943 0.64 
Difference in proportion between men and women  (95% CI) 0.11 (0.08, 0.14) 
 p< 0.001 
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Comparison of weight loss in men compared with women across trials 
For the analysis comparing mean weight loss between men and women, a total of 13 studies had 
eligible data [24-27,29,31-34,36-38,40]. There were a total of 5890 participants with 2213 (37.6%) 
men and 3677 (62.4%) women (Figures 1- 2).  There were two analyses for comparing mean weight 
change in kg and percentage weight change between the sexes.  Both analyses showed there were no 
significant differences in weight change between men and women recruited to these studies. There 
was considerable heterogeneity in both meta-analyses.  Few studies gave sufficient information on the 
actual prescribed calorie deficit, or whether this took account of sex. It is, therefore, unclear whether 
prescribed calorie deficit had any impact on our result.  Similarly, it is unclear whether men or women 
adhere better to lifestyle prescription, and consequently it is unclear whether adherence had any 
influence on this result.  
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Figure 1 Difference between mean weight loss in kg between men and women 
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Figure 2 Difference in percentage weight loss from baseline between men and women 
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Low fat reducing diet with/without exercise with/without behaviour change 
Six trials [24,25,32-34,39] investigated a low fat reducing diet (LFRD) compared with exercise and/or 
behavioural therapy or in combination with these comparators. 
 
Low fat reducing diet and behaviour change training 
One trial [24] examined LFRD and behaviour change training compared to control after one year (men 
-11.80kg, 95% CI -16.86 to -6.74; women -5.60kg, 95% CI -8.74 to -4.57). The dietary prescription of 
1200kcal/day for weight reduction and 1880kcal/day for maintenance was not reported to differ by 
sex.  Women had greater reductions in systolic blood pressure.  At seven years, the mean weight 
reduction in the intervention group was 8.7kg in men and 3.5kg in women (control data not available).   
 
Low fat reducing diet and exercise 
It was unclear in the Finnish Diabetes Prevention Study whether men and women at high risk of 
developing type 2 diabetes responded differently to a LFRD and an exercise programme, individually 
tailored to achieve 5% weight loss compared to controls. Both sexes had a reduced incidence of 
diabetes after a median follow up of four years (hazard ratio for diabetes incidence 0.43, 95% CI 0.22 
to 0.81 for men; 0.61, 95% CI 0.39 to 0.97 for women; no statistically significant interaction between 
sex and intervention) [39].  Weight change data by sex for this trial have not so far been published. 
 
Vanninen and colleagues [25,49] investigated the effects of LFRD and exercise advice against a 
control group involving basic conventional education materials only.  Details of the exact dietary 
prescription were not provided.  All participants in this trial were non-insulin dependent, type 2 
diabetics.  Women in the trial had higher average BMI than men (34kg/m2 versus 31kg/m2, 
respectively). After one year, men in the intervention group had lost significantly more weight than 
men in the control group (p = 0.04). Women in the intervention group also lost more weight than 
women in the control group, although the difference was not significant. Women in the intervention 
group were reported to have improved HbA1c, fasting glucose and cholesterol compared to controls, 
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but results are difficult to interpret in this small study as the control group had much poorer glycaemic 
control and cholesterol at baseline.  
 
Volpe and colleagues [32] investigated the effects of a supervised exercise programme for an initial 
six months versus LFRD, or both interventions together.  The goal was for participants to lose 0.5 to 
1.0kg per week, although it is unclear whether this related to the dietary prescription alone or also took 
account of the exercise programme.  By 12 months, there were no significant weight differences 
between the different intervention groups for women or men.  The effects of the interventions on 
cardiovascular risk factors and waist circumference were also inconsistent in men and women at 12 
months. 
 
Low fat reducing diet, exercise and behaviour change training 
The Diabetes Prevention Program [34,52] randomised individuals at high risk for diabetes to an 
intensive LFRD with an exercise programme and behavioural therapy, metformin or placebo treatment 
groups with an average follow-up of 2.8 years.  For the purposes of this review, we present data for the 
intensive intervention and placebo groups only.  The aim of the intensive lifestyle programme was to 
lose 7% of initial body weight and maintain this weight loss throughout the trial. The calorie goals 
were calculated based on initial weight loss and a deficit of 500-1000kcal/day, together with an 
increase in physical activity equivalent to 700kcal/week.  After one year, men in the intensive lifestyle 
group had lost an average of 8% (6.0kg) of body weight, compared to 7% (4.6kg) for women (reported 
p = 0.02) [53].  By the end of follow-up, the average weight change for the intensive lifestyle group 
was -4.43kg (SD 7.30) [34].  The 58% reduction in development of type 2 diabetes from the intensive 
lifestyle intervention compared to placebo did not differ by sex (reported p = 0.71) [53].  Race and sex 
were reported as significant influences on weight loss in the intensive lifestyle group, with black 
women reported as having a significantly lower weight loss pattern than other groups [34]. 
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Ma and colleagues [31] evaluated two adaptations to the DPP lifestyle intervention for use with 
participants with pre-diabetes and/or metabolic syndrome: a coach-led, group-based intervention and a 
self-directed, DVD-based intervention. A usual care comparison group acted as the control group.  
The intervention was delivered in 12 weekly face-to-face classes to the coach-led group or via a home-
based DVD to the self-directed participants. As with the DPP intensive lifestyle intervention, the goals 
of the active interventions were to achieve 7% weight loss and engage in 150 minutes of moderate 
physical activity per week.  At 15 months, men had lost more weight than women in the self-directed 
group (-5.1kg, SE 1.0 versus -3.9kg, SE1.1) whereas women lost more weight than men in the coach-
led group (-6.9kg, SE 1.1 versus -5.6, SE 1.1) and the usual care group (-3.0kg, SE 1.1 versus -2.0kg, 
SE 1.1).  Differences by group between men and women were reported as not statistically significant. 
 
The Look AHEAD (Action for Health in Diabetes) study [33] recruited overweight or obese type 2 
diabetics to a trial comparing an intensive lifestyle intervention, comprising a LFRD, some meal 
replacements, exercise advice and intensive behavioural therapy.  The intensive lifestyle intervention 
was designed to produce a minimum weight loss of 7% of initial body weight during the first year, 
with dietary instructions tailored to initial body weight.  The control group received diabetes support 
and education.  The trial was designed to examine the effect of the intensive lifestyle intervention on 
cardiovascular morbidity and mortality, and was stopped early at a median follow-up of 9.6 years on 
the basis of a futility analysis [54].  Wadden and colleagues [33,50] reported 4-year and 8-year weight 
data by sex for the active intervention group.  The men in this group consistently lost more weight 
than the women at each annual assessment, except year eight (men -9.3kg (8.5%) at year 1 follow-up, 
-5.2kg (4.8%) year 4 and -4.6kg (9.7%) at year 8; women -8.1kg (8.5%) year 1, -4.4kg (4.6%) year 4 
and -4.8kg (7.8%) at year 8), although differences were not statistically significant.  The prescribed 
calorie intake was based on weight but it is not clear whether the calorie intake also took account of 
sex.  Attendance and treatment contacts were similar for men and women. 
 
Several ancillary studies have reported sex effects in the Look AHEAD study.  Stewart and colleagues 
[47] investigated changes in body image in men and women in one centre.  Both men and women in 
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the intervention group had significant reductions in body image dissatisfaction compared with the 
control group after one year (reported P<0.05, P< 0.01, respectively).  Men in both the intervention 
and control groups showed greater reduction in dissatisfaction compared to women (-8.1 (SE 1.59) 
versus -6.3 (SE 0.94) for the intervention group and -3.3 (SE 1.66) versus -2.3 (SE 0.96) for the 
control group).  
 
Schwartz and colleagues [48] investigated the effect of the weight loss intervention on bone mineral 
density (BMD) in five of the Look AHEAD centres.  After one year, at the total hip, the difference in 
bone loss between the two treatment groups was significantly greater for men (-1.48% versus 0.02% in 
controls) than for women (-1.44% versus -0.61%) (reported p for interaction = 0.04). The authors 
reported that there was no evidence of an interaction by sex at the other bone sites. 
 
Gorin and colleagues [46] assessed the impact of the intervention and control treatments on untreated 
spouses of the Look AHEAD participants in three sites.  Spouses were not formally involved in either 
treatment group and were not expected to attend group meetings but their weight was measured by the 
trial outcome assessors.  Participants in the active intervention group were taught ways to enhance 
social support to promote their weight loss efforts (e.g. how to communicate assertively with family 
members about desired food modifications).  Participants in the control group received no such 
training.  After one year, spouses of the intensive lifestyle participants had a weight change of -2.4kg 
(SD 4.5) compared to -0.2kg (SD 3.3) for spouses of control participants (reported p < 0.001).  The 
authors reported no effect by sex or baseline weight of the spouse. 
 
Physical activity and healthy diet advice and behavioural therapy versus usual care for weight loss 
The PROACTIVE trial [40] randomised abdominally obese participants to receive an intervention 
offering physical activity and individually tailored counselling or to usual care (lifestyle advice from a 
primary care physician).  Calorie reduction was not explicitly mentioned in either group.  Both men 
and women lost more weight in the intervention group initially but, after two years, only men in the 
intervention group continued with significant weight and waist circumference reduction compared to 
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the usual care group.  Weight losses were small and mean group changes from baseline did not exceed 
2.5kg at any time point.  No significant differences between the intervention or usual care groups were 
seen for cardiometabolic risk factors for either men or women, apart from metabolic syndrome which 
was significantly reduced in men after two years. 
 
Comparisons of different types of diet for weight loss 
Shai and colleagues [41] investigated the effectiveness of a LFRD (1500kcal/day for women, 
1800kcal/day for men), a Mediterranean diet with equivalent calories, and a low carbohydrate (20g per 
day initially increasing to 120g per day) non-restricted calorie diet in the Dietary Intervention 
Randomised Controlled Trial (DIRECT).  At the end of the two year trial, the only significant 
difference between men and women occurred in the LFRD group.  Men lost significantly more weight 
than women in this group (mean change -3.4kg (SD 4.34) versus -0.1kg (SD 4.06) reported p=0.004). 
 
Wing and colleagues [35] compared an intermittent very low calorie diet (400-500kcal/day) with a low 
calorie, low fat diet (1000-1200kcal/day) in a one year trial in participants with type 2 diabetes.  Both 
groups also received behavioural therapy, physical activity advice and deposited $150, which was 
refunded depending on compliance.  Women in the very low calorie diet group lost significantly more 
weight after one year than women in the low calorie, low fat diet group (14.1kg versus 8.6kg, reported 
p<0.023) whereas men had comparable losses in both treatment groups (15.4kg and 15.5kg 
respectively, p not reported). 
 
Evans and colleagues [27] evaluated sex differences resulting from weight loss achieved via a high 
protein (dietary protein approximately 30% of energy intake with a carbohydrate/protein ratio <1.5) or 
high carbohydrate diet (dietary protein approximately 15% of energy intake, carbohydrate/protein ratio 
>3.5). Both diets were equal in energy, providing 1700 kcal/day for women and 1900 kcal/day for 
men, with 30% of energy from total fat.  Participants attended weekly 1-hour meetings with a research 
dietician and each group followed an education programme focused on diet compliance and exercise 
guidance, monitored by 3-day weighed food records, daily activity logs and armband accelerometers.  
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At 12 months, men lost more weight in the high carbohydrate group (-14.2kg, SD 9.4) than the high 
protein group (-10kg, SD 6.3), whereas women had slightly greater weight loss in the high protein 
group (-7.5kg, SD 4.7 versus -7kg, SD 4.1).  Although men lost more total weight than women, there 
was no reported statistical interaction of diet and sex for percent weight loss at 12 months. 
 
Types of behaviour change training for weight loss 
Heitzmann and colleagues [23] randomised participants with type 2 diabetes to behavioural, cognitive 
or cognitive behavioural therapy weight loss conditions or to a control group who received muscle 
relaxation training and factual diabetes information only.  Participants in all groups received dietary 
advice from a registered nutritionist and were given individual physical activity advice, but details of 
the advice were not provided.  At 18 months across all intervention groups it was reported that men 
lost an average of 3.63kg while women gained an average of 0.04kg.  There was a borderline 
significant interaction (reported p=0.057) for weight loss by sex. Men experienced significantly 
greater reduction in HbA1c than women, indicating better control of blood glucose (reported p<0.05), 
but this difference was not significant between experimental groups.   
 
Intensive inpatient rehabilitation versus community programmes for weight loss 
Two trials by Hakala and colleagues [36,37] investigated the effectiveness of interventions with an 
initial inpatient rehabilitation setting against a community setting, for people at least 50% overweight.  
The rehabilitation interventions included a dietary intervention (1200kcal/day), intensive group 
behavioural and educational sessions along with prescribed physical activity programmes and 
occupational therapy, as well as individual nutritionist and physician counselling. Details of the 
programmes after the initial 1200kcal/day prescription were not provided.  
 
In the earlier trial [36], men lost more weight in the community setting than the inpatient setting, 
possibly due to individual counselling, differences were statistically significant for years one and two 
(mean change -13.1kg (SD 8.8) versus -26.2kg (SD 10.3) reported p<0.01 and -1.8kg (7.4) versus -
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15.6kg (SD 12.0) reported p<0.01, respectively).  Differences were not significantly different for 
women. 
 
In the trial by Hakala and colleagues from 1994 [37], a similar comparison between initial intensive 
inpatient rehabilitation was compared with a community setting, delivered in group format only. When 
both rehabilitation and community interventions were delivered to men in groups, the rehabilitation 
setting produced favourable results, although differences were statistically significant over the first 
two years but not at five years (men at two years -8.50kg, 95% CI -16.67 to -0.33).  For women, the 
rehabilitation setting produced no significant benefit in weight loss over the community intervention 
for any time point from one to five years. 
 
Type of provider and tailoring for dietary intervention for weight loss 
No obvious difference between type 2 diabetic men and women was observed for weight loss at one 
year when health care was provided by a doctor with an initial written leaflet or a nurse specialist with 
individual dietary instructions and further follow-up (men -0.75kg, 9%% CI -4.93 to 3.43; women -
2.19kg, 95% CI -6.66 to 2.28) [38].  
 
When given a choice between attending a weight loss programme delivered by a commercial provider 
or the UK NHS, women were more likely to choose a commercial provider than men, despite some 
commercial groups being labelled as ‘male friendly’ (81% versus 47%) [44].   The Lighten Up trial 
[44] randomised participants to one of three weight loss programmes run by commercial companies 
(Weight Watchers, Slimming World and Rosemary Conley) or to one of three programmes delivered 
via the NHS (NHS Size Down, a General Practitioner or a pharmacist), or participants were 
randomised to a choice group where they were able to choose one of the six programmes depending 
on their preference.  For the control group, participants received vouchers for 12 free sessions at a 
council-leisure centre.   
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At one year, only Weight Watchers produced weight loss significantly different from the control group 
(adjusted mean difference -2.49kg, 95% CI -4.15 to -0.83, baseline observation carried forward for 
drop outs, BOCF).  The authors found no statistically significant interaction between sex and weight 
loss programme. 
 
Further BOCF data supplied by the authors show significant weight losses from baseline for women 
for the choice programme, Size Down, Rosemary Conley, Slimming World and Weight Watchers, and 
the control group.   For men, Size Down, Rosemary Conley and Weight Watchers produced significant 
weight losses from baseline.  The control group and Slimming World also produced significant 
changes from baseline for men, but only in the last observation carried forward analysis (where 
missing data are imputed with the last recorded weight). 
  
Spouse involvement in programme 
Wing and colleagues [26] randomised obese type 2 diabetic participants to receive a behavioural 
weight loss programme either with their obese spouse (together) or without their spouse (alone).  All 
participants received behavioural therapy consisting of stimulus control, problem solving, assertion, 
goal setting and cognitive techniques.  Participants were also advised to monitor calorie intake to 
between 1200-1500 kcals/day and set stepwise goals for walking.  Weight loss of participants treated 
alone and together was not significantly different after one year, although men lost more weight when 
treated alone (men alone -7.25kg, together -1.25kg) whereas women did better when treated together 
(women alone -2.26kg, together -5.89kg).  Spouses of both sexes lost more weight in the together 
condition than the alone condition (p<0.05). 
 
Golan and colleagues (Golan 2010) also described the ‘halo’ effect of the DIRECT dietary 
interventions on 74 wives of men participating in the trial.  The wives were not randomised to any 
treatment group but were invited to attend the 90 minute support group meetings held every two 
months for the DIRECT participants.  At the end of the trial, men whose wives had attended support 
meetings lost more weight than men who did not have spousal support both as an entire group and 
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within each diet group but differences were not significant.  For both the wives of the DIRECT 
husbands and the female DIRECT participants, differences in weight loss were significantly greater in 
the Mediterranean and low carbohydrate groups than for the LFRD group (reported p=0.034 and 
p<0.05 respectively).   Husbands of the DIRECT women did not participate in the sub-study. 
 
Similarly, Gorin and colleagues [46] assessed the impact of the intervention and control treatments on 
untreated spouses of the Look AHEAD participants in three sites.  Spouses were not formally involved 
in either treatment group and were not expected to attend group meetings.  After one year, spouses of 
the intensive lifestyle participants had a weight change of -2.4kg (SD 4.5) compared to -0.2kg (SD 
3.3) for spouses of control participants.  The authors reported no effect by sex or baseline weight of 
the spouse. 
 
Modification of the home environment 
Gorin and colleagues [28] randomised overweight and obese participants and an overweight or obese 
household member willing to act as a support partner, mostly spouses, to a LFRD with exercise advice 
and behavioural therapy or to the same treatment package but with modifications made to the home 
environment.  Modifications targeted physical and social cues in the home.  Only participants received 
treatment in the standard programme while both participants and partners received treatment in the 
modified programme.  At 18 months, women lost significantly more weight in the modified 
programme than in the standard programme (-8.1kg (SD 1.1) versus -4.2kg (SD 1.1) reported 
p=0.014).  Men lost more weight in the standard programme, however (-10.0kg (SD 2.3) versus -4.6kg 
(SD 2.2) although differences were not significant (reported p=0.065).  Partners in the modified 
programme lost more weight than partners in the standard programme at 18 months, regardless of sex.   
 
Telephone versus mail advice and behaviour change for weight loss 
Jeffery and colleagues [30] compared the effectiveness of an intervention including weight reduction, 
physical activity advice and behaviour change techniques delivered via telephone or mail.  A control 
group received usual care.  Details of the dietary and physical activity advice were unclear. Only men 
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lost significantly more weight at one year compared to usual care [telephone -1.42kg (95% CI -2.71 to 
-0.13), mail -1.38kg (95%CI -2.61 to -0.15)]. There were no significant differences in weight losses 
between telephone and mail groups for men or women. 
 
Varying monetary contracts for weight loss and maintenance 
Jeffery and colleagues [29] investigated the effect of financial contracts for weight loss and weight 
maintenance in men and women.  All participants paid a $150 deposit at the start of a 16-week weight 
loss phase consisting of nutrition, physical activity and behaviour change technique education sessions 
with a weight loss goal of 0.9kg/week.  Participants in the constant contract groups were refunded $30 
for each successive group average weight loss of 5lb (2.27kg) and participants in the increasing 
contract groups were refunded $5, $10, $20, $40 and $75 for successive 5lb group weight losses.   
 
Following the weight loss phase, 17 men and 25 women were randomised to receive either intensive 
or non-specific weight maintenance sessions.  Those enrolling in the maintenance phase paid a $100 
deposit, which was returned in $25 increments for attendance at quarterly group sessions.  Those not 
enrolling in the maintenance phase were contacted at the one year follow-up assessment only.  The 
authors reported that weight loss at one year was not statistically associated with recruitment source, 
contract type or sex.  However, percentage change in weight showed that women lost significantly 
more weight than men (reported p<0.05, data not provided).  During weight maintenance it was 
reported that the only significant effect was for women in the intensive maintenance condition who 
outperformed men for this contract type (reported p<0.006, data not provided). 
 
On demand diet versus regularly repeated diet for weight loss maintenance 
Lantz and colleagues [43] randomised participants to receive either an on-demand very low calorie 
diet (VLCD) (450kcal/day), after 16 weeks of the VLCD, or a regularly repeated VLCD. After the 
initial 16 weeks, participants in the intermittent on demand group followed a 500 kcal/day deficit diet 
but changed to the 450kcal/day diet when their individual body weight reached predetermined cut-off 
levels throughout the trial period.  Participants in the regularly repeated group followed the same 500 
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kcal/day deficit diet but used the VLCD for a fortnight every third month.  At two years, men in the 
on-demand intermittent diet group had significantly better weight change than men in the regularly 
repeated diet group (-10.50kg, 95%CI -16.6 to -4.84 ).  There were no significant differences between 
diets for women (1.80kg, 95% CI 5.23 to 1.63). 
 
Orlistat versus placebo for weight maintenance 
Richelsen and colleagues [42] investigated the effect of orlistat in people with type 2 diabetes, 
impaired fasting glucose or dyslipidaemia.  Before randomisation, participants all initially lost at least 
5% of their body weight by following a very low calorie diet of 600-800 kcal/day over an eight week 
period.  All participants were then randomised to receive lifestyle counselling including a 600kcal/day 
deficit low fat diet with either orlistat 120mg three times daily or matching placebo capsules.  Weight 
change from the start of the diet to three years, analysed using last observation carried forward for 
dropouts, was reported as significantly greater for women in the orlistat group compared to the 
placebo group [-9.7kg (-8.4%) versus -6.3kg (-5.3%) P<0.02], although for men the difference was 
reported as not significant; orlistat versus placebo groups [-8.9kg (-8.3%) versus -8.1kg (-7.5%)]. 
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Discussion  
Despite the very large number of long-term RCTs of weight loss interventions, we found only 22, 
mostly underpowered, RCTs that provided outcomes separately for men and women in the same trial.  
Almost all trials reported data only for completers, inflating the effectiveness of interventions.  
Reporting was poor for blinding of outcome assessment, details of randomisation, and equity and 
sustainability items. 
 
Men represented around a third of the participants in these trials.  It is unclear why fewer men than 
women were recruited.  The variety of different interventions, and small size of many of the studies, 
means that conclusions about best study designs for men, and whether services should be different, 
can only be very tentative from this review.  Few of the trials considered truly comparable 
interventions and, in most cases, data were unsuitable for pooling in a formal meta-analysis.  
 
Our analyses of trial retention showed that men were significantly more likely to complete trials than 
women, with only one small trial [27] showing better retention for women than men.  We are unable to 
comment on possible explanations for differential drop out between men and women from the 
available data.  Nevertheless, this finding suggests that, while fewer men are likely to join weight loss 
programmes, once they do join they show commitment to ‘stick with’ the programme.  This highlights 
the importance of understanding which weight loss programmes are likely to attract and retain men. 
 
Our analyses of weight loss showed no significant overall differences between men and women, 
although this was based on a limited number of trials.  However, this result must be interpreted with 
considerable caution as in most of the trials it was impossible to conclude that men and women were 
being managed in a comparable fashion.  Dietary and physical activity prescriptions were rarely 
described, with little evidence that allowance was made for the greater body size and muscle mass of 
obese men in the prescription of the calorie deficit.  Our findings are in contrast to recent meta-
analyses conducted by Stroebele-Benschop and colleages [55] and Williams and colleagues [56],  
which found significantly higher relative weight loss for men than women, although both analyses 
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contained few studies, effect sizes were small and both authors note that results are not conclusive.  
Neither review examined the details of the individual studies to see if the prescribed energy deficit and 
exercise regime would have led to different weight loss by sex. As with our review, most of the 
included studies did not consider gender differences as their primary outcome. Although Williams 
argues that there is little evidence to support different weight loss strategies for men and women, we 
argue that the within-study differences found in our review do show variation in response to 
interventions between men and women. 
 
There was no clear evidence that the type of diet influenced long term weight loss in men [35], apart 
from a better response to LFRDs in one trial [41] and for LFRD (in some cases with meal 
replacements), exercise advice and behaviour change training [33].  Men outperformed women when 
they had to reduce their calorie intake in response to body weight cues rather than following a VLCD 
at regular intervals [43].  Regulating calorie intake by responding to one’s own body may offer a 
greater sense of personal control over weight loss, which might be more important to men than to 
women. It could be that this form of weight regulation was seen as less regimented by the men and 
was therefore favoured due to the tendency for men to be reluctant to follow formal diet plans [57].  
Diabetic men following LFRDs may be at greater risk of developing osteoporosis than diabetic women 
[48]. 
 
Although men performed well in terms of weight loss in group settings [24,29,33,37,44], more 
favourable results were produced where individual support or tailored advice were delivered to men as 
well as the group intervention.  This may also offer men a greater sense of personal control or men 
may have greater educational needs for weight loss reduction than women.  Tailoring by ethnicity may 
be more important for women than men [33], although whether this is true for ethnic groups outside 
the US requires further investigation.  
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Support from a spouse [45] or partner and learning how to enhance social support from family 
members [46] may also be particularly helpful for men, but having a spouse attend the same 
programme was not helpful for men [26].   
 
In the Lighten up trial [44] the authors noted that, while men performed well in the programmes 
delivered by commercial companies, fewer than half picked these programmes when choice of 
provider was freely available.  The authors suggested that commercial companies may appear more 
female-orientated.  By contrast, NHS delivered programmes may have been perceived by men as 
purely concerned with improving health rather than physical appearance, which may be more 
acceptable to traditional concepts of masculinity.  Whether programmes are GP or nurse-led seems 
unimportant [38]. 
 
There was some suggestion from the trials of Richelsen and colleagues for orlistat [42], and of Jeffery 
and colleagues for financial contracts [29] that men may do less well than women in weight 
maintenance with these interventions. 
 
Our data confirm those of Pagoto and colleagues’ systematic review [4]; that men are less likely to 
take part in RCTs, and comprised 27% of all participants in their RCTs, compared with 37% in the 
studies providing data here.  The Pagoto and colleagues’ review did not focus on recruitment by sex in 
the same trial. They noted that very few (19/244) studies reported interaction effects by sex.   
 
Moroshko and colleagues did not find that being male or female was a significant influence on 
dropping out of weight loss interventions [5].  However, they did not use meta-analysis of sex-specific 
data from within randomised trials.  From the 16 studies they found, three reported higher attrition in 
women, one in men, and the rest found no significant association with sex.   
 
It is possible that the style of delivery could be as important as the content of the intervention for men 
and women, with men preferring simple, fact-based language with individual feedback [10,58,59].  
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Two recent trials [10,60] of men-only interventions achieved effective long-term weight loss results.  
Both trials developed interventions that were designed to appeal to men both in content and through 
the use of carefully targeted, male-orientated humour and sporting affiliation.  The success of these 
trials highlights how providing gender-tailored interventions can improve the effectiveness of weight 
loss interventions.  Young and colleagues [17] reviewed the effectiveness of male-only weight loss 
and maintenance interventions,.  Although the authors included studies of shorter duration than those 
included in our review, they reported that the characteristics associated with more effective 
interventions included younger age of participants, greater frequency of contact, group face-to-face 
contact, and prescribed energy restriction.  All but one of our trials appeared to have prescribed a 
dietary energy deficit.  We did not have sufficient data to examine factors such as age, group settings 
or frequency of contact. 
 
Conclusions 
Notwithstanding the limitations of our evidence base, we found some evidence that men and women 
do respond differently to weight management programmes.  Weight reduction for men is best achieved 
and maintained with a low fat reducing diet,  with or without physical activity or behaviour change 
training (e.g. self-monitoring goal setting, prompting self-monitoring, providing feedback, review of 
goals).  Some individual support and tailoring appears to be more useful to men than women.  Support 
of a spouse or partner may also be beneficial.  Men are less likely to engage in weight loss 
interventions than women, but are less likely to drop out once engaged. Given these differences, it is 
important that future mixed-sex trials report results separately for men and women.  As discussed by 
Lovejoy [61], it would also be helpful if unadjusted results were reported along with results that have 
been adjusted for sex so as to avoid obscuring any sex-related differences in treatment effects. 
 
Given the lower proportion of men in weight loss programmes, we suggest that having a better idea of 
the views, of what is an essentially a heterogeneous group, is important in weight loss or weight 
maintenance endeavours, as it is likely to improve the uptake and effectiveness of programmes 
intended for men.  Interventions that are appealing to men are likely to encourage men to join weight 
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loss programmes and promote greater adherence, thus improving the effectiveness of the intervention. 
We did not find explicit evidence suggesting men had been consulted in the design of studies or 
interventions, yet it has been argued for some decades [62-66] that health improvement programmes 
are more likely to appear relevant and salient if they are informed by the views of the intended 
beneficiaries.  Consideration needs to be given to interventions that are appealing to men, delivered in 
environments where men feel comfortable, and reflect the differing requirements for individual advice 
and support between men and women.  This may be best delivered via men-only interventions and 
further research should explore this option. Services need to be formally evaluated, not only for 
effectiveness, but also to establish whether they reflect the diversity of their population.   Presently, 
the evidence from RCTs is limited in quality and quantity.  Rigorous feasibility studies and piloting 
with service user input at all stages is required prior to definitive long-term (at least one year follow-
up) randomised controlled trials that make a distinction between support for the initial weight loss and 
a different or modified programme to help maintain that weight loss.  
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